Annovis Bio Launches Proposed Public Offering of Common Stock and Warrants

Bitget2026/11/04 21:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Annovis Bio launched a proposed underwritten public offering of common stock or pre-funded warrants, with accompanying warrants to purchase common stock.
The common stock or pre-funded warrants and accompanying warrants will be issued separately but must be purchased together.
Net proceeds will fund buntanetap clinical development for Alzheimer's and Parkinson's diseases, working capital and general corporate purposes.
Canaccord Genuity is the sole bookrunner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611041607PRIMZONEFULLFEED9870573) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Annovis Bio Launches Proposed Public Offering of Common Stock and Warrants

You may also like

Crypto prices